Hepatitis B and C virus infections and the risk of biliary tract cancers: a meta-analysis of observational studies

Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin N Am. 2019;33(4):1045–62.

Article  Google Scholar 

Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018;142(12):2471–7.

CAS  Article  Google Scholar 

Bassig BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, Gao YT, Purdue MP, et al. Serologic markers of viral infection and risk of non-Hodgkin lymphoma: a pooled study of three prospective cohorts in China and Singapore. Int J Cancer. 2018;143(3):570–9.

CAS  Article  Google Scholar 

Li M, Gan Y, Fan C, Yuan H, Zhang X, Shen Y, et al. Hepatitis B virus and risk of non-Hodgkin lymphoma: an updated meta-analysis of 58 studies. J Viral Hepat. 2018;25(8):894–903.

CAS  Article  Google Scholar 

Li Y, Li Y, Zhang L, Li W. Hepatitis C virus infection and risk of multiple myeloma: evidence from a meta-analysis based on 17 case-control studies. J Viral Hepat. 2017;24(12):1151–9.

CAS  Article  Google Scholar 

Wang P, Jing Z, Liu C, Xu M, Wang P, Wang X, et al. Hepatitis C virus infection and risk of thyroid cancer: a systematic review and meta-analysis. Arab J Gastroenterol. 2017;18(1):1–5.

Article  Google Scholar 

Hepatitis B vaccines. Wkly Epidemiol Rec. 2004;79(28):255–63.

Chan E, Berlin J. Biliary tract cancers: understudied and poorly understood. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(16):1845–8.

CAS  Article  Google Scholar 

Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428–44.

CAS  Article  Google Scholar 

Tian T, Song C, Jiang L, Dai J, Lin Y, Xu X, et al. Hepatitis B virus infection and the risk of cancer among the Chinese population. Int J Cancer. 2020;147(11):3075–84.

CAS  Article  Google Scholar 

Xiong J, Wang Y, Chen G, Jin L. Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study. Gut. 2020;69(12):2265–7.

Article  Google Scholar 

Zhou Z, Nie SD, Jiang B, Wang J, Lv P. Risk factors for extrahepatic cholangiocarcinoma: a case-control study in China. Eur J Cancer Prev. 2019;28(4):254–7.

Article  Google Scholar 

Xiong J, Lu X, Xu W, Bai Y, Huang H, Bian J, et al. Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in China. Cancer Manag Res. 2018;10:3849–55.

Article  Google Scholar 

Peng YC, Lin CL, Hsu WY, Chow WK, Lee SW, Yeh HZ, et al. Association between cholangiocarcinoma and proton pump inhibitors use: a nested case-control study. Front Pharmacol. 2018;9:718.

Article  Google Scholar 

Mahale P, Engels EA, Koshiol J. Hepatitis B virus infection and the risk of cancer in the elderly US population. Int J Cancer. 2019;144(3):431–9.

CAS  Article  Google Scholar 

Li M, Li J, Li P, Li H, Su T, Zhu R, et al. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. J Gastroenterol Hepatol. 2012;27(10):1561–8.

Article  Google Scholar 

Zhang H, Zhu B, Zhang H, Liang J, Zeng W. HBV infection status and the risk of cholangiocarcinoma in Asia: a meta-analysis. Biomed Res Int. 2016;2016:3417976.

PubMed  PubMed Central  Google Scholar 

Li H, Hu B, Zhou ZQ, Guan J, Zhang ZY, Zhou GW. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J Surg Oncol. 2015;13:161.

Article  Google Scholar 

Zhou Y, Zhao Y, Li B, Huang J, Wu L, Xu D, et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer. 2012;12:289.

Article  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

Article  Google Scholar 

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.

CAS  Article  Google Scholar 

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.

CAS  Article  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

CAS  Article  Google Scholar 

Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372(1732):20160274.

Article  Google Scholar 

Zhou H, Wang H, Zhou D, Wang H, Wang Q, Zou S, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer. 2010;46(6):1056–61.

CAS  Article  Google Scholar 

Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int. 2010;30(2):215–21.

Article  Google Scholar 

Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 2008;122(8):1849–53.

CAS  Article  Google Scholar 

Lee BS, Park EC, Park SW, Nam CM, Roh J. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. World J Gastroenterol. 2015;21(2):502–10.

Article  Google Scholar 

Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54(2):463–71.

Article  Google Scholar 

Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004;95(7):592–5.

CAS  Article  Google Scholar 

Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control. 2001;12(10):959–64.

CAS  Article  Google Scholar 

Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol. 2001;36(10):651–60.

CAS  Article  Google Scholar 

Sze KM, Chu GK, Lee JM, Ng IO. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology. 2013;57(1):131–9.

CAS  Article  Google Scholar 

Liu HB, Qian ZY, Wang BS, Tong SX. Detection of markers of hepatitis viral infection in the tissue of bile duct carcinoma. Chin Med J (Engl). 2008;121(12):1143–4.

Article  Google Scholar 

Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol. 1998;4(5):392–6.

CAS  Article  Google Scholar 

Einav S, Sklan EH, Moon HM, Gehrig E, Liu P, Hao Y, et al. The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection. Hepatology. 2008;47(3):827–35.

CAS  Article  Google Scholar 

Li T, Li D, Cheng L, Wu H, Gao Z, Liu Z, et al. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann Surg Oncol. 2010;17(7):1937–44.

Article  Google Scholar 

Fillipowicz EA, Xiao S, Sower LE, Weems J, Payne DA. Detection of HCV in bile duct epithelium by laser capture microdissection (LCM). In Vivo. 2005;19(4):737–9.

CAS  PubMed  Google Scholar 

Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48(1):308–21.

CAS  Article  Google Scholar 

Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater. Am J Surg Pathol. 2014;38(10):1371–9.

Article  Google Scholar 

留言 (0)

沒有登入
gif